State Street’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-447,807
Closed -$2.2M 4420
2024
Q1
$2.2M Buy
447,807
+38,745
+9% +$184K ﹤0.01% 3249
2023
Q4
$1.49M Buy
409,062
+2,734
+0.7% +$7.49K ﹤0.01% 3390
2023
Q3
$902K Buy
406,328
+17,900
+5% +$50K ﹤0.01% 3556
2023
Q2
$1.32M Buy
388,428
+145,631
+60% +$525K ﹤0.01% 3538
2023
Q1
$969K Hold
242,797
﹤0.01% 3545
2022
Q4
$1.32M Buy
242,797
+3,063
+1% +$18K ﹤0.01% 3494
2022
Q3
$1.21M Buy
239,734
+35,454
+17% +$175K ﹤0.01% 3562
2022
Q2
$778K Buy
+204,280
New +$1.3M ﹤0.01% 3686

State Street's TGAN Position: Q2 2024 in Review

State Street sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 447,807 shares — an estimated $2.2M sold.

State Street first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $2.2M in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

  • State Street reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • State Street sold 447,807 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $2.2M.
  • State Street first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • State Street's Transphorm, Inc. Common Stock position peaked at $2.2M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.